Chronic kidney disease (CKD) patients are at risk of secondary hyperparathyroidism (HPT-II) due to high PTH levels and various metabolic disturbances, such as calcitriol deficiency, hypocalcemia, and hyperphosphatemia [7, 8]. This evidence concerns the gene PTH and secondary hyperparathyroidism.